Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LISDEXAMFETAMINE DIMESYLATE vs LONCASTUXIMAB TESIRINE-LPYL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LISDEXAMFETAMINE DIMESYLATE vs LONCASTUXIMAB TESIRINE-LPYL: Safety Overview

Metric LISDEXAMFETAMINE DIMESYLATE LONCASTUXIMAB TESIRINE-LPYL
Total FAERS Reports 17,054 202
Deaths Reported 122 58
Death Rate 0.7% 28.7%
Hospitalizations 2,028 34
Average Patient Age 27.0 yrs 77.3 yrs
% Female Patients 54.7% 48.1%
FDA Approval Date Aug 25, 2023 N/A
Manufacturer Rhodes Pharmaceuticals N/A
Route ORAL N/A
Marketing Status Prescription Prescription